Division of Johnson & Johnson
Latest From Ethicon Inc.
R&D Roundup, October 2019: TCT Brings More Transcatheter Valve Results, New Product Launches, Reassuring Data On Paclitaxel Risk
An overview of October’s ten most-read Medtech Insight articles on topics related to research and development of new medical technology.
Johnson & Johnson and subsidiary Ethicon will pay $117m to settle state lawsuits alleging that their marketing misrepresented the safety and risks of transvaginal mesh devices.
Johnson & Johnson's medical device businesses grew 5.3% on an organic basis in the third quarter, led by the Biosense Webster electrophysiology business. The company is increasing R&D investment, especially in robotic surgery, to boost its surgery and orthopedics businesses.
The Echelon circular powered stapler for colorectal, gastric and thoracic surgery features Ethicon’s 3D stapling technology to evenly distribute compression and a gripping-surface technology that reduces compressive forces on tissue. The company expects the new system will reduce leaks at the staple line without compromising blood or lymphatic perfusion.
- Implantable Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Therapeutic Areas
- Wound Healing & Tissue Repair
- North America
- Parent & Subsidiaries
Johnson & Johnson
- Acclarent Inc.
- Advanced Sterilization Products
- Auris Health Inc.
- CardioVations Inc.
- Guangzhou Bioseal Biotechnology Co. Ltd.
- Gynecare Inc.
- Heartport Inc.
- Johnson & Johnson Medical Inc.
- Medtrex Inc.
- Mentor Corp.
- Omrix Biopharmaceuticals Inc.
- Torax Medical Inc.
- Vascular Control Systems Inc.
- Ethicon Inc.
- Senior Management
- Contact Info
Phone: (908) 218-0707
Rte. 22 West
Somerville, NJ 08876
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.